Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
61.8M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
26.3M
-
Shares change
-
-450K
-
Total reported value, excl. options
-
$236M
-
Value change
-
-$5.57M
-
Number of buys
-
30
-
Number of sells
-
-20
-
Price
-
$8.97
Significant Holders of Aura Biosciences, Inc. - Common Stock (AURA) as of Q3 2023
65 filings reported holding AURA - Aura Biosciences, Inc. - Common Stock as of Q3 2023.
Aura Biosciences, Inc. - Common Stock (AURA) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 61.8M outstanding shares and own 42.61% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (5.36M shares), Medicxi Ventures Management (Jersey) Ltd (3.04M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.02M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.88M shares), CITADEL ADVISORS LLC (2.48M shares), BlackRock Inc. (1.86M shares), VANGUARD GROUP INC (1.03M shares), GOLDMAN SACHS GROUP INC (993K shares), Nantahala Capital Management, LLC (744K shares), and Rock Springs Capital Management LP (723K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.